Barclays raised the firm’s price target on Thermo Fisher (TMO) to $625 from $585 and keeps an Overweight rating on the shares post the Q3 report. The company reported relatively solid results across the board, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher Scientific Reports Strong Q3 2025 Results
- Thermo Fisher’s Strong Q3 Performance and Positive Outlook Drive Buy Rating
- Thermo Fisher Scientific Reports Strong Q3 Earnings
- Thermo Fisher price target raised to $650 from $610 at BofA
- Thermo Fisher price target raised to $580 from $545 at Leerink